Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for IVF outcomes in women with polycystic ovary syndrome and prior failed IVF
IRCT20250225064853N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of melatonin in polycystic ovary syndrome (PCOS) and female infertility (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Mature oocyte count (MII) and Fertilization rate. Started Oct 2025; status: completed.
02
Drugs
melatonin
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on IRCT20250225064853N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250225064853N3.